Company Profile

Molecular Partners AG (NASDAQ: MOLN)
5:30 PM UTC, 07/03/24
Last: $6.62 Change: -0.38 %Change: -5.43% Volume: 6,789
Detailed Quote
Open: $ 6.58   Volume: 6,789
High: $ 6.99   Yield(%) 0.00
Low: $ 6.46   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 232.27M
EPS ($) -2.01   Shares Out: 33.18M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 80.18
% Price Change (last 13 weeks): 79.49
% Price Change (last 26 weeks): 67.87
% Price Change (last 52 weeks): 14.85
% Price Change (year to date): 67.47
Management Effectiveness
Return on Equity (%): -29.74
Return on Assets (%): -26.57
Return on Invested Capital (%): -28.17
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): -880.70
Operating Profit Margin (%): -868.26
Price & Volume
50-day Moving Average: $4.50
200-day Moving Average: $3.76
Avg. Daily Vol. (last 50 days): 32,024
Avg. Daily Vol. (last 200 days): 13,923
52-wk high: $12.70
52-wk low: $3.32
Bid: $6.65
Ask: $10.53
Company Information
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company products include Abicipar, MP0250/MP0274 and Clinical Trials. The company was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Plückthun, and Michael Tobias Stumpp on November 22, 2004 and is headquartered in Schlieren, Switzerland.
Molecular Partners AG
Wagistrasse 14
Schlieren ZH 8952

Phone: 41.44.755.77.00
Fax: 41.44.755.77.07
http://www.molecularpartners.com
Per Share Data
Earnings (1year) ($): -2.01
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 6.38
Cash Flow ($): -2.02
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 17.49
Price/Book (x): 0.66
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 13.35
Current Ratio (x): 13.35
LT Debt/Equity (x): 1.39
Total Debt/Equity (x): 2.07



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.